261 related articles for article (PubMed ID: 21215698)
1. ACE2, a promising therapeutic target for pulmonary hypertension.
Shenoy V; Qi Y; Katovich MJ; Raizada MK
Curr Opin Pharmacol; 2011 Apr; 11(2):150-5. PubMed ID: 21215698
[TBL] [Abstract][Full Text] [Related]
2. Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy.
Bradford CN; Ely DR; Raizada MK
Curr Hypertens Rep; 2010 Aug; 12(4):212-9. PubMed ID: 20556668
[TBL] [Abstract][Full Text] [Related]
3. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.
Han SX; He GM; Wang T; Chen L; Ning YY; Luo F; An J; Yang T; Dong JJ; Liao ZL; Xu D; Wen FQ
Toxicol Appl Pharmacol; 2010 May; 245(1):100-7. PubMed ID: 20178811
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies.
Papavassiliou KA; Gogou VA; Papavassiliou AG
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139269
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK
Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels.
Li G; Xu YL; Ling F; Liu AJ; Wang D; Wang Q; Liu YL
Chin Med J (Engl); 2012 Apr; 125(8):1381-8. PubMed ID: 22613639
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 as a therapeutic target for heart failure.
Chamsi-Pasha MA; Shao Z; Tang WH
Curr Heart Fail Rep; 2014 Mar; 11(1):58-63. PubMed ID: 24293035
[TBL] [Abstract][Full Text] [Related]
8. The role of ACE2 in cardiovascular physiology.
Oudit GY; Crackower MA; Backx PH; Penninger JM
Trends Cardiovasc Med; 2003 Apr; 13(3):93-101. PubMed ID: 12691672
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2: a new target for neurogenic hypertension.
Feng Y; Xia H; Santos RA; Speth R; Lazartigues E
Exp Physiol; 2010 May; 95(5):601-6. PubMed ID: 19923158
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme 2 in lung diseases.
Kuba K; Imai Y; Penninger JM
Curr Opin Pharmacol; 2006 Jun; 6(3):271-6. PubMed ID: 16581295
[TBL] [Abstract][Full Text] [Related]
12. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
Shenoy V; Ferreira AJ; Qi Y; Fraga-Silva RA; Díez-Freire C; Dooies A; Jun JY; Sriramula S; Mariappan N; Pourang D; Venugopal CS; Francis J; Reudelhuber T; Santos RA; Patel JM; Raizada MK; Katovich MJ
Am J Respir Crit Care Med; 2010 Oct; 182(8):1065-72. PubMed ID: 20581171
[TBL] [Abstract][Full Text] [Related]
13. Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome.
Kaparianos A; Argyropoulou E
Curr Med Chem; 2011; 18(23):3506-15. PubMed ID: 21756232
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
[TBL] [Abstract][Full Text] [Related]
15. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S; Kaplan M; Gamliel-Lazarovich A
Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
[TBL] [Abstract][Full Text] [Related]
16. ACE2/Ang-(1-7) signaling and vascular remodeling.
Zhang Z; Chen L; Zhong J; Gao P; Oudit GY
Sci China Life Sci; 2014 Aug; 57(8):802-8. PubMed ID: 25104453
[TBL] [Abstract][Full Text] [Related]
17. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
18. Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.
Iwata M; Cowling RT; Yeo SJ; Greenberg B
J Mol Cell Cardiol; 2011 Oct; 51(4):542-7. PubMed ID: 21147120
[TBL] [Abstract][Full Text] [Related]
19. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.
Ferreira AJ; Shenoy V; Yamazato Y; Sriramula S; Francis J; Yuan L; Castellano RK; Ostrov DA; Oh SP; Katovich MJ; Raizada MK
Am J Respir Crit Care Med; 2009 Jun; 179(11):1048-54. PubMed ID: 19246717
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease.
Wysocki J; González-Pacheco FR; Batlle D
Curr Hypertens Rep; 2008 Feb; 10(1):70-7. PubMed ID: 18367030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
